chr7-151187179-C-CAG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001142459.2(ASB10):c.-51_-50dupCT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.24 in 1,483,822 control chromosomes in the GnomAD database, including 7,124 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 4939 hom., cov: 22)
Exomes 𝑓: 0.24 ( 2185 hom. )
Consequence
ASB10
NM_001142459.2 5_prime_UTR
NM_001142459.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.160
Genes affected
ASB10 (HGNC:17185): (ankyrin repeat and SOCS box containing 10) The protein encoded by this gene is a member of the ankyrin repeat and SOCS box-containing (ASB) family of proteins. The SOCS box serves to couple suppressor of cytokine signaling (SOCS) proteins and their binding partners with the elongin B and C complex, possibly targeting them for degradation. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 7-151187179-C-CAG is Benign according to our data. Variant chr7-151187179-C-CAG is described in ClinVar as [Benign]. Clinvar id is 402398.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB10 | NM_001142459.2 | c.-51_-50dupCT | 5_prime_UTR_variant | 1/6 | ENST00000420175.3 | NP_001135931.2 | ||
ASB10 | NM_001142460.1 | c.-51_-50dupCT | 5_prime_UTR_variant | 1/5 | NP_001135932.2 | |||
ASB10 | NM_080871.4 | c.271+271_271+272dupCT | intron_variant | NP_543147.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB10 | ENST00000420175.3 | c.-51_-50dupCT | 5_prime_UTR_variant | 1/6 | 1 | NM_001142459.2 | ENSP00000391137.2 | |||
ASB10 | ENST00000275838.5 | c.-51_-50dupCT | 5_prime_UTR_variant | 1/5 | 1 | ENSP00000275838.1 | ||||
ASB10 | ENST00000377867.7 | c.271+271_271+272dupCT | intron_variant | 2 | ENSP00000367098.3 | |||||
ASB10 | ENST00000415615.1 | n.*121+73_*121+74dupCT | intron_variant | 4 | ENSP00000410871.1 |
Frequencies
GnomAD3 genomes AF: 0.257 AC: 38552AN: 150140Hom.: 4933 Cov.: 22
GnomAD3 genomes
AF:
AC:
38552
AN:
150140
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.238 AC: 317270AN: 1333586Hom.: 2185 Cov.: 0 AF XY: 0.236 AC XY: 155203AN XY: 658378
GnomAD4 exome
AF:
AC:
317270
AN:
1333586
Hom.:
Cov.:
0
AF XY:
AC XY:
155203
AN XY:
658378
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.257 AC: 38583AN: 150236Hom.: 4939 Cov.: 22 AF XY: 0.251 AC XY: 18388AN XY: 73366
GnomAD4 genome
AF:
AC:
38583
AN:
150236
Hom.:
Cov.:
22
AF XY:
AC XY:
18388
AN XY:
73366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at